A Study to Investigate the Efficacy and Safety of Two Different Doses of Twice Daily Distal Jejunal-release Dextrose Beads Formulations Combined With a Gel Composition Compared to Placebos in Obese Subjects With Weight Related Comorbidities

NCT07008456 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

102

Enrollment

INDUSTRY

Sponsor class

Conditions

Obese With Comorbidities
Obese Patients (BMI ≥ 30 kg/m²)

Interventions

DRUG: APHD-012
DRUG: APHD-002
DRUG: APHP-012
DRUG: APHP-002

Sponsor

Aphaia Pharma US LLC